Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replicating Huntington's disease phenotype in experimental animals.

E Brouillet1, F Condé, M F Beal

  • 1URA CEA CNRS 2210, Service Hospitalier Frédéric Joliot, Orsay, France. brouille@shfj.cea.fr

Progress in Neurobiology
|October 9, 1999
PubMed
Summary

Huntington's disease (HD) is modeled in animals using 3-nitropropionic acid (3NP) to block energy production. This toxin successfully replicates HD's key motor, cognitive, and striatal degeneration symptoms, offering a valuable research model.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optogenetic Tractography for anatomo-functional characterization of cortico-subcortical neural circuits in non-human primates.

Scientific reports·2018
Same author

Incidence of asthma in young adults from Castellon, Spain: A prospective cohort study.

Allergologia et immunopathologia·2017
Same author

Incidence of allergic rhinitis in a cohort of young adults from 13-15 years old to 23-25 years old in Castellon (Spain).

Allergologia et immunopathologia·2016
Same author

Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.

Cell death and differentiation·2015
Same author

Impaired brain creatine kinase activity in Huntington's disease.

Neuro-degenerative diseases·2010
Same author

Thalamic projections of the vestibular nuclei in the cat as revealed by retrograde transport of horseradish peroxidase.

Neuroscience letters·2009

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Huntington's disease (HD) is an inherited neurodegenerative disorder with no effective treatments.
  • The molecular cause is an expanded polyglutamine tract in the huntingtin protein.
  • Mitochondrial dysfunction is a suspected key factor in HD's pathology.

Purpose of the Study:

  • To investigate the mitochondrial hypothesis of Huntington's disease.
  • To evaluate 3-nitropropionic acid (3NP) as a model for HD's neurodegeneration.

Main Methods:

  • Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3NP) to rodents and non-human primates.
  • Chronic blockade of succinate oxidation to induce energy impairment.
  • Behavioral and neuropathological evaluations.

Related Experiment Videos

Main Results:

  • 3NP administration replicated key clinical and pathophysiological hallmarks of HD.
  • Observed symptoms included choreiform movements, cognitive deficits, and striatal degeneration.
  • 3NP preferentially degenerated medium-sized spiny GABAergic neurons, mirroring HD.

Conclusions:

  • Partial, prolonged energy impairment by 3NP effectively models Huntington's disease.
  • This 3NP model is valuable for understanding HD pathogenesis and testing therapies.
  • The study supports the role of mitochondrial dysfunction in HD progression.